IAM
ALXN

Impax Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Impax Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,049
Closed -$200K – 213
2015
Q4 		$200K Buy
+1,049
New +$183K 0.01% 191
2015
Q3 		– Sell
-8,415
Closed -$1.52M – 201
2015
Q2 		$1.52M Buy
8,415
+7
+0.1% +$1.21K 0.08% 149
2015
Q1 		$1.46M Sell
8,408
-1,621
-16% -$293K 0.08% 154
2014
Q4 		$1.86M Buy
10,029
+60
+0.6% +$11.1K 0.11% 149
2014
Q3 		$1.65M Sell
9,969
-95
-0.9% -$15.6K 0.11% 142
2014
Q2 		$1.57M Hold
10,064
– – 0.1% 142
2014
Q1 		$1.53M Buy
10,064
+2
+0% +$318 0.1% 138
2013
Q4 		$1.34M Sell
10,062
-41
-0.4% -$4.92K 0.08% 137
2013
Q3 		$1.17M Sell
10,103
-3,536
-26% -$388K 0.08% 140
2013
Q2 		$1.26M Buy
+13,639
New +$1.31M 0.09% 129

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return